Research on the impact of R&D Expenses and Sales Investmenton the Enterprise Performance?Based on empirical analysis from the GEM Pharmaceutical Industry

DOI

10.2991/sschd-16.2016.98How to use a DOI?

Keywords

R&D expenses; sales investment; enterprises performance; pharmaceutical Industry

Abstract

Technological innovation and marketing capability are important means for enterprises to enhance the competitive advantage. This paper used the listed companies of the GEM Pharmaceutical Industry as samples, 2012--2014 years as the test period, to examine the relationship between R&D expenses, sales investment and the enterprise performance. We find that R&D expenses has a significant negative correlation with the current enterprise performance and the lagged one period performance, but the correlation with lagged two period performance is not significant;and sales investment has a significant positive correlation with the current enterprise performance.

Copyright

© 2016, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Zhen-Yi Wang
AU  - Peng-Tao Zhou
AU  - Meng Xie
AU  - Yu-Xi Huang
PY  - 2015/12
DA  - 2015/12
TI  - Research on the impact of R&D Expenses and Sales Investmenton the Enterprise Performance?Based on empirical analysis from the GEM Pharmaceutical Industry
BT  - Proceedings of the 2nd Annual International Conference on Social Science and Contemporary Humanity Development
PB  - Atlantis Press
SP  - 496
EP  - 503
SN  - 2352-5398
UR  - https://doi.org/10.2991/sschd-16.2016.98
DO  - 10.2991/sschd-16.2016.98
ID  - Wang2015/12
ER  -